BFC Planning’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$48.2K Sell
543
-239
-31% -$22.6K ﹤0.01% 1571
2026
Q2
$67.3K Buy
782
+348
+80% +$30.5K ﹤0.01% 1402
2026
Q1
$39.2K Buy
434
+20
+5% +$1.84K ﹤0.01% 1434
2025
Q4
$37.2K Buy
414
+202
+95% +$19.2K ﹤0.01% 1485
2025
Q3
$20.9K Sell
212
-44
-17% -$4.36K ﹤0.01% 1555
2025
Q2
$23.4K Sell
256
-690
-73% -$66.7K ﹤0.01% 1427
2025
Q1
$107K Sell
946
-85
-8% -$9.09K 0.01% 836
2024
Q4
$109K Buy
1,031
+421
+69% +$45.2K 0.01% 829
2024
Q3
$65.9K Buy
+610
New +$66.6K 0.01% 1018

Other funds holding ZBH

BFC Planning's ZBH Position: Q3 2026 in Review

BFC Planning reduced its Zimmer Biomet (ZBH) stake by 31% in Q3 2026, selling an estimated $22.6K and leaving 543 shares worth $48.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1571.

BFC Planning first reported a position in ZBH in Q3 2024 and has held it in 9 quarters since. The position peaked at $109K in Q4 2024. 798 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

  • BFC Planning held 543 shares of Zimmer Biomet worth $48.2K as of Q3 2026.
  • BFC Planning sold 239 Zimmer Biomet shares in Q3 2026, an estimated $22.6K.
  • Zimmer Biomet made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #1571 holding.
  • BFC Planning first reported a position in Zimmer Biomet in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Zimmer Biomet position peaked at $109K in Q4 2024.
  • 798 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.